Acrolein consumption induces systemic dyslipidemia and lipoprotein modification.
Conklin DJ, Barski OA, Lesgards JF, Juvan P, Rezen T, Rozman D, Prough RA, Vladykovskaya E, Liu S, Srivastava S, Bhatnagar A.
Conklin DJ, et al. Among authors: rezen t.
Toxicol Appl Pharmacol. 2010 Feb 15;243(1):1-12. doi: 10.1016/j.taap.2009.12.010. Epub 2009 Dec 23.
Toxicol Appl Pharmacol. 2010.
PMID: 20034506
Free PMC article.